Ticker Details
PMV Pharmaceuticals, Inc.
IPO Date:	September 25, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$67.2M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.43 | 3.40%
Avg Daily Range (30 D):	$0.03 | 2.40%
Avg Daily Range (90 D):	$0.04 | 3.06%

Institutional Daily Volume
Avg Daily Volume:	.44M
Avg Daily Volume (30 D):	.42M
Avg Daily Volume (90 D):	.53M

Trade Size
Avg Trade Size (Sh.):	115
Avg Trade Size (Sh.) (30 D):	253
Avg Trade Size (Sh.) (90 D):	295

Institutional Trades
Total Institutional Trades:	875
Avg Institutional Trade:	$2.33M
Avg Institutional Trade (30 D):	$4.46M
Avg Institutional Trade (90 D):	$4.46M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.22M
Avg Closing Trade (30 D):	$6.87M
Avg Closing Trade (90 D):	$6.87M
Avg Closing Volume:	147.98K

News

Apr 22, 2026 @ 12:00 PM PMV Pharmaceuticals Announces Board Chair Transiti... Source: Na

Mar 6, 2026 @ 1:00 PM PMV Pharmaceuticals Reports Full Year 2025 Financi... Source: Pmv Pharmaceuticals, Inc.

Jun 3, 2024 @ 1:55 PM Here's Why PMV Pharmaceuticals (PMVP) Could be Gre... Source: Zacks Equity Research

May 29, 2024 @ 11:00 AM Foundation Medicine and PMV Pharma Announce Collab... Source: PMV Pharmaceuticals, Inc.

May 28, 2024 @ 1:47 PM Here's Why You Should Buy Acrivon Therapeutics (AC... Source: Zacks Equity Research

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.49	$-.34	$-.34
Diluted EPS	$-1.49	$-.34	$-.34
Revenue	$5.38M	$.98M	$1.23M
Gross Profit
Net Income / Loss	$-78.34M	$-18.04M	$-18.04M
Operating Income / Loss	$-83.66M	$-19.02M	$-19.24M
Cost of Revenue
Net Cash Flow	$-13.36M	$M	$1.65M
PE Ratio